Key terms
About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AZN news
Today
7:20am ET
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN)
Today
5:27am ET
3 Best Healthcare Stocks to Buy in April 2024, According to Analysts
Yesterday
7:27am ET
AstraZeneca’s Q1 2024: Revenue and Dividend Leap
Yesterday
5:52am ET
AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage
Yesterday
5:49am ET
AstraZeneca reports Q1 core EPS $2.06, consensus $1.22
Yesterday
5:38am ET
AZN Earnings: AstraZeneca Soars on Impressive Q1 Results
Apr 23
11:16am ET
AstraZeneca put volume heavy and directionally bearish
Apr 23
6:30am ET
AstraZeneca reports Voydeya approved in EU as PNH add-on treatment
Apr 19
6:21pm ET
VGK vs. EZU: Which Is the Better European Stock ETF?
Apr 18
9:41am ET
Unusually active option classes on open April 18th
Apr 16
12:49pm ET
AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
Apr 16
7:12am ET
AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC
Apr 16
6:20am ET
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
Apr 11
2:27pm ET
AstraZeneca’s AGM: Resolutions Passed with Support
Apr 11
7:05am ET
AstraZeneca announces FDA approval for Fasenra
Apr 11
6:14am ET
AstraZeneca increases 2024 dividend by 7% to $3.10 per share
Apr 09
9:00pm ET
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
Apr 08
8:41am ET
Nuvectis says NXP900 demonstrates robust activity in NSCLC
Apr 08
6:58am ET
AstraZeneca’s Enhertu Wins US Approval for Tumours
Apr 07
6:04am ET
ENHERTU approved for treatment of unresectable or metastatic HER2 positive
Apr 05
7:03am ET
AstraZeneca releases ADRIATIC Phase III trial results on IMFINZI
Apr 05
6:57am ET
AstraZeneca’s Imfinzi Shows Promise in Lung Cancer Trial
Apr 05
5:56am ET
AstraZeneca: Imfinzi significantly improved OS and PFS in LS-SCLS in trial
Apr 04
12:06pm ET
AstraZeneca call volume above normal and directionally bullish
Apr 04
4:32am ET
AstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan
Apr 02
1:58pm ET
AstraZeneca Reports Voting Rights and Share Capital
Apr 02
9:28am ET
AstraZeneca’s Voydeya Wins FDA Approval
Apr 02
8:28am ET
AstraZeneca’s Cancer Drug Closer to FDA Approval
Apr 02
7:04am ET
AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S.
Apr 01
7:10am ET
AstraZeneca announces FDA approval of Voydeya
Apr 01
6:10am ET
AstraZeneca shareholders urged to oppose EUR 18.7M pay plan for CEO, FT says
No recent press releases are available for AZN
AZN Financials
Key terms
Ad Feedback
AZN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AZN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range